Status of Generic Albuterol Products Return to Non-preferred August 28, 2020
In response to reported drug shortages for albuterol products in the Bronchodilators, Short-Acting Beta Agonist Inhalers drug class, FirstCare temporarily removed the non-preferred status from the generic formulations on March 20, 2020. FirstCare will reverse this change in status because we determined sufficient availability in the market. For more information including the preferred PDL options, click here.
* Required field
ATTENTION: By clicking “Continue”, you will be leaving the FirstCare Medicare Dual SNP (HMO SNP) site pages. If you wish to remain on these pages, simply click “Cancel” or close this box.